Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison R Jilbert

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 3, 2015
Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinomaThomas Tu, Magdalena A Budzinska, Nicholas A Shackel, et al.
Vaccine|September 14, 2010
The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccinesFeng Feng, Chee Quin Teoh, Qiao Qiao, et al.
Virology|August 14, 2010
The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesisGeorget Y Reaiche, Marc F Le Mire, William S Mason, et al.
Journal of Virology|September 15, 2005
Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infectionMarc F Le Mire, Darren S Miller, Wendy K Foster, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2003
Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infectionWendy K Foster, Darren S Miller, Patricia L Marion, et al.
Journal of Virology|April 14, 2005
Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infectionWendy K Foster, Darren S Miller, Catherine A Scougall, et al.
The Journal of General Virology|February 13, 2001
Sequence comparison of an Australian duck hepatitis B virus strain with other avian hepadnavirusesMiriam Triyatni, Peter L Ey, Thien Tran, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2003
Hepatocyte turnover during resolution of a transient hepadnaviral infectionJesse Summers, Allison R Jilbert, Wengang Yang, et al.
Journal of Virology|February 15, 2005
Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivityHaitao Guo, William S Mason, Carol E Aldrich, et al.
Virology|August 26, 2004
Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virusYuao Zhu, John M Cullen, Carol E Aldrich, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Liver International : Official Journal of the International Association for the Study of the Liver|February 3, 2015
Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinomaThomas Tu, Magdalena A Budzinska, Nicholas A Shackel, et al.
Vaccine|September 14, 2010
The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccinesFeng Feng, Chee Quin Teoh, Qiao Qiao, et al.
Virology|August 14, 2010
The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesisGeorget Y Reaiche, Marc F Le Mire, William S Mason, et al.
Journal of Virology|September 15, 2005
Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infectionMarc F Le Mire, Darren S Miller, Wendy K Foster, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2003
Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infectionWendy K Foster, Darren S Miller, Patricia L Marion, et al.
Journal of Virology|April 14, 2005
Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infectionWendy K Foster, Darren S Miller, Catherine A Scougall, et al.
The Journal of General Virology|February 13, 2001
Sequence comparison of an Australian duck hepatitis B virus strain with other avian hepadnavirusesMiriam Triyatni, Peter L Ey, Thien Tran, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2003
Hepatocyte turnover during resolution of a transient hepadnaviral infectionJesse Summers, Allison R Jilbert, Wengang Yang, et al.
Journal of Virology|February 15, 2005
Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivityHaitao Guo, William S Mason, Carol E Aldrich, et al.
Virology|August 26, 2004
Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virusYuao Zhu, John M Cullen, Carol E Aldrich, et al.
Pageof 3